In one paragraphArticle in Biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors at 7 institutions in 3 countries.
Swarnalatha YanamadalaDepartment of Biotechnology, Sathyabama Institute of Science and Technology, Chennai 600119, India.
Sivakumar ShanthirappanDepartment of Gunapadam, National Institute of Siddha, Chennai 600047, India.ORCID 0000-0003-4477-1141 Sidhika KannanCentre for Nanoscience and Nanotechnology, Sathyabama Institute of Science and Technology, Chennai 600119, India.
Narendran ChiterasuCentre for Nanoscience and Nanotechnology, Sathyabama Institute of Science and Technology, Chennai 600119, India.ORCID 0000-0001-9607-5397 Kumaran SubramanianCentre for Drug Discovery and Development, Sathyabama Institute of Science and Technology, Chennai 600119, India.
Lamya Ahmed Al-KeridisDepartment Biology, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh P.O. Box 84428, Saudi Arabia.
Tarun Kumar UpadhyayDepartment of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India.ORCID 0000-0002-2551-9779 Nawaf AlshammariDepartment of Biology, College of Science University of Hail, Hail P.O. Box 2440, Saudi Arabia.
Mohd SaeedDepartment of Biology, College of Science University of Hail, Hail P.O. Box 2440, Saudi Arabia.ORCID 0000-0003-3443-386X Guru Prasad SrinivasanCentre for Research, Bharath Institute for Higher Education and Research, Chennai 600073, India.
Rohini KarunakaranUnit of Biochemistry, Faculty of Medicine, AIMST University, Bedong 08100, Malaysia.ORCID 0000-0001-7076-192X Sathyabama Institute of Science and Technology · INUniversity of Ha'il · SAAIMST University · MYBharath University · INCentral Council for Research in Siddha · INParul University · INPrincess Nourah bint Abdulrahman University · SA
Funding
Princess Nourah bent Abdulrahman University researcher supporting programme number PNURSP 2022 R82
6 · The paper itselfAbstract
Though there are several advancements and developments in cancer therapy, the treatment remains challenging. In recent years, the antimicrobial peptides (AMPs) from traditional herbs are focused for identifying and developing potential anticancer molecules. In this study, AMPs are identified from
Indexed as
AMPsanti-proliferativecyclic peptidecytotoxicityde novo sequencingorbitideszebrafish
Identifiers
PMID36979104
PMCPMC10045366
OpenAlexW4323569744
What OpenQuestion holds
Textfull text, public
LicenceCC BY
measurements read25
Read underepoch 390